Emma McIntosh

Emma McIntosh is a Professor of Health Economics and Health Technology Assessment at the University of Glasgow, with extensive research experience spanning over two decades. Her academic appointments include leadership roles in major research initiatives across public health, clinical economics, and global health.

Professor McIntosh earned her PhD in Economics from the University of Aberdeen (2003), preceded by an MSc in Health Economics from the University of York (1994-1995) and a BA Hons in Economics from the University of Stirling (1989-1993). Her educational background established the foundation for her specialized expertise in health economics.

Her research focuses on rigorous economic evaluations of healthcare interventions across diverse clinical domains. Key interests include musculoskeletal disorders, Parkinson's disease economics, antimicrobial resistance policy, maternal and child health interventions, and climate-resilient urban health systems. Professor McIntosh frequently employs mixed methods approaches, combining quantitative economic analysis with qualitative process evaluations to assess complex healthcare interventions.

Analysis of her recent publication record (2021-2025) reveals a strong emphasis on global health applications, particularly in Tanzania, alongside significant contributions to methodological advancements in evaluating complex interventions. Her work consistently bridges economic analysis with clinical outcomes, demonstrating particular strength in quality of life assessment integration.

• NIHR Funding Board Committee Member (NIHR PHR)
• Principal Investigator on multiple major grants from MRC, EPSRC, NIHR, and NERC
• Lead of the NIHR Global Health Research Group on arthritis in Tanzania

Professor McIntosh maintains an active research program with continuous funding since 2007, currently overseeing multiple large-scale projects including the GALLANT climate resilience initiative (2022-2027) and Quantum Imaging project (2021-2026). Her research group operates at the intersection of health economics, clinical medicine, and public health policy, with strong international collaborations particularly in sub-Saharan Africa.

Her laboratory focus centers on the NIHR Global Health Research Group, which conducts economic evaluations of rheumatology services in Tanzania while addressing broader health system challenges. This work exemplifies her commitment to applying health economics principles in resource-limited settings to inform policy decisions.